Has Ranilo Vasquez, MD received payments from drug or device companies?

Yes. Drug and device makers reported $15,351 in general payments to Ranilo Vasquez, MD across 840 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ranilo Vasquez, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ranilo Vasquez, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ranilo Vasquez, MD

Internal Medicine · Broken Arrow, OKNPI 1669449211

Payments from drug & device makers

$15,351in general payments, 2019–2025

Across 840 payments — averaging $18.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

GSK$2K
AstraZeneca$2K
AbbVie$2K
Novo Nordisk$963
Boehringer Ingelheim$853
Pfizer$807
plus $8K from 46 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
GSK	111	$1,833
AstraZeneca	66	$1,679
AbbVie(2 entities)	101	$1,533
Novo Nordisk	63	$963
Boehringer Ingelheim	43	$853
Pfizer	54	$807
Bayer	36	$669
Lilly USA, LLC	40	$641
Amgen	35	$589
Kowa Pharmaceuticals America, Inc.	47	$589
Johnson & Johnson	23	$530
Amarin Pharma, Inc.	28	$498
Abbott	23	$455
Astellas Pharma US Inc	24	$449
Kvk-tech, Inc.	1	$365
Takeda Pharmaceuticals U.S.A., Inc.	17	$329
Novartis	17	$272
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	12	$220
Exact Sciences	9	$191
Dexcom, Inc.	3	$168
Arbor Pharmaceuticals, Inc.	10	$166
Merck	10	$137
Eisai Inc.	7	$133
Insulet Corporation	1	$127
Azurity Pharmaceuticals, Inc.	5	$99
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	5	$89
Daiichi Sankyo Inc.	4	$87
Edwards Lifesciences	1	$79
Sumitomo Pharma America, Inc.	3	$65
Biogen	4	$56
Xeris Pharmaceuticals, Inc.	2	$54
Alnylam Pharmaceuticals Inc.	3	$50
Sanofi-aventis U.S. LLC	2	$44
Avanir Pharmaceuticals, Inc.	3	$43
Otsuka America Pharmaceutical, Inc.	2	$43
Inspire Medical Systems, Inc.	2	$39
Mannkind Corporation	2	$38
Ironwood Pharmaceuticals, Inc	2	$37
Phathom Pharmaceuticals, Inc.	2	$34
E.r. Squibb & Sons, L.L.C.	2	$33
Boston Scientific	2	$32
Corium, LLC	2	$31
IBSA Pharma Inc.	2	$29
Ultragenyx Pharmaceutical Inc.	1	$23
Biohaven Pharmaceuticals, Inc.	1	$22
Viatris Specialty LLC	1	$22
Mylan Specialty L.p.	1	$20
Bioventus LLC	1	$19
Biohaven Pharmaceutical Holding Company Ltd.	1	$19
Verona Pharma, Inc.	1	$16
Idorsia Pharmaceuticals US Inc	1	$16
Paratek Pharmaceuticals, Inc.	1	$15

How this compares

$15,351 in reported general payments places this provider in the 95th percentile of 840 internal medicine providers in Oklahoma.

See all internal medicine providers in Oklahoma →

Medicare billing

Part B allowed, 2024

$116,317

Medicare patients

368

Services billed

2,032

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Broken Arrow

Riley HillBroken Arrow$14K
Rim TabbaaBroken Arrow$12K
Al-Ola AbdallahTulsa$10.1M
Melita TateTulsa$9.1M
Sagila GeorgeOklahoma City$1.8M
Ryan MorganOklahoma City$775K
Renae MayerTulsa$766K
George FreemanIdabel$742K
Elise WiesnerNorman$584K
Steve EgwuonwuLawton$464K

See the full list for Oklahoma →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →